nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—hypertension—focal segmental glomerulosclerosis	0.511	1	CtDrD
Candesartan—AGTR1—focal segmental glomerulosclerosis	0.37	1	CbGaD
Candesartan—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0324	0.421	CbGbCtD
Candesartan—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0226	0.294	CbGbCtD
Candesartan—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0219	0.285	CbGbCtD
Candesartan—AGTR1—nephron—focal segmental glomerulosclerosis	0.0049	0.383	CbGeAlD
Candesartan—AGTR1—endothelium—focal segmental glomerulosclerosis	0.00231	0.181	CbGeAlD
Candesartan—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.0577	CcSEcCtD
Candesartan—Tasosartan—AGTR2—focal segmental glomerulosclerosis	0.00119	0.252	CrCbGaD
Candesartan—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0478	CcSEcCtD
Candesartan—AGTR1—nephron tubule—focal segmental glomerulosclerosis	0.00106	0.0827	CbGeAlD
Candesartan—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00102	0.0794	CbGeAlD
Candesartan—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.0447	CcSEcCtD
Candesartan—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00094	0.0419	CcSEcCtD
Candesartan—AGTR1—kidney—focal segmental glomerulosclerosis	0.000929	0.0727	CbGeAlD
Candesartan—AGTR1—cortex of kidney—focal segmental glomerulosclerosis	0.000905	0.0708	CbGeAlD
Candesartan—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000791	0.0353	CcSEcCtD
Candesartan—Azilsartan medoxomil—AGTR1—focal segmental glomerulosclerosis	0.000735	0.155	CrCbGaD
Candesartan—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.000696	0.0311	CcSEcCtD
Candesartan—Forasartan—AGTR1—focal segmental glomerulosclerosis	0.000683	0.144	CrCbGaD
Candesartan—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000664	0.0296	CcSEcCtD
Candesartan—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000627	0.028	CcSEcCtD
Candesartan—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000605	0.027	CcSEcCtD
Candesartan—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.0259	CcSEcCtD
Candesartan—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.000504	0.0225	CcSEcCtD
Candesartan—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000504	0.0394	CbGeAlD
Candesartan—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00047	0.021	CcSEcCtD
Candesartan—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000458	0.0204	CcSEcCtD
Candesartan—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000419	0.0187	CcSEcCtD
Candesartan—Tasosartan—AGTR1—focal segmental glomerulosclerosis	0.000414	0.0872	CrCbGaD
Candesartan—PTGS1—kidney—focal segmental glomerulosclerosis	0.000409	0.032	CbGeAlD
Candesartan—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000376	0.0168	CcSEcCtD
Candesartan—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000372	0.0166	CcSEcCtD
Candesartan—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000359	0.016	CcSEcCtD
Candesartan—Valsartan—AGTR1—focal segmental glomerulosclerosis	0.000359	0.0756	CrCbGaD
Candesartan—Olmesartan—AGTR1—focal segmental glomerulosclerosis	0.00035	0.0737	CrCbGaD
Candesartan—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000348	0.0156	CcSEcCtD
Candesartan—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00034	0.0152	CcSEcCtD
Candesartan—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000339	0.0151	CcSEcCtD
Candesartan—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.0151	CcSEcCtD
Candesartan—Telmisartan—AGTR1—focal segmental glomerulosclerosis	0.000338	0.0711	CrCbGaD
Candesartan—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000328	0.0147	CcSEcCtD
Candesartan—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000325	0.0145	CcSEcCtD
Candesartan—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000323	0.0144	CcSEcCtD
Candesartan—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.0139	CcSEcCtD
Candesartan—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.0138	CcSEcCtD
Candesartan—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000309	0.0138	CcSEcCtD
Candesartan—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000309	0.0138	CcSEcCtD
Candesartan—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.0137	CcSEcCtD
Candesartan—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000305	0.0136	CcSEcCtD
Candesartan—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000303	0.0135	CcSEcCtD
Candesartan—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000275	0.0215	CbGeAlD
Candesartan—Irbesartan—AGTR1—focal segmental glomerulosclerosis	0.000272	0.0573	CrCbGaD
Candesartan—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000271	0.0121	CcSEcCtD
Candesartan—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000269	0.012	CcSEcCtD
Candesartan—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000249	0.0111	CcSEcCtD
Candesartan—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000246	0.011	CcSEcCtD
Candesartan—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000242	0.0108	CcSEcCtD
Candesartan—ABCB1—kidney—focal segmental glomerulosclerosis	0.000242	0.0189	CbGeAlD
Candesartan—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000241	0.0108	CcSEcCtD
Candesartan—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000235	0.0184	CbGeAlD
Candesartan—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000235	0.0105	CcSEcCtD
Candesartan—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000232	0.0104	CcSEcCtD
Candesartan—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.0102	CcSEcCtD
Candesartan—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.0102	CcSEcCtD
Candesartan—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.0102	CcSEcCtD
Candesartan—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000228	0.0102	CcSEcCtD
Candesartan—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.0096	CcSEcCtD
Candesartan—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00948	CcSEcCtD
Candesartan—AGTR1—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.000201	0.106	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0002	0.00893	CcSEcCtD
Candesartan—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000197	0.0088	CcSEcCtD
Candesartan—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000196	0.00874	CcSEcCtD
Candesartan—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000195	0.00872	CcSEcCtD
Candesartan—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00863	CcSEcCtD
Candesartan—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00019	0.00846	CcSEcCtD
Candesartan—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00845	CcSEcCtD
Candesartan—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00018	0.00802	CcSEcCtD
Candesartan—Losartan—AGTR1—focal segmental glomerulosclerosis	0.000175	0.0369	CrCbGaD
Candesartan—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000175	0.00779	CcSEcCtD
Candesartan—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000174	0.00775	CcSEcCtD
Candesartan—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000174	0.00775	CcSEcCtD
Candesartan—AGTR1—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.000172	0.0906	CbGpPWpGaD
Candesartan—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000158	0.00703	CcSEcCtD
Candesartan—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000155	0.00694	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.000155	0.082	CbGpPWpGaD
Candesartan—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00015	0.00671	CcSEcCtD
Candesartan—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000145	0.00648	CcSEcCtD
Candesartan—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00014	0.00623	CcSEcCtD
Candesartan—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000139	0.00618	CcSEcCtD
Candesartan—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000138	0.00618	CcSEcCtD
Candesartan—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000138	0.00614	CcSEcCtD
Candesartan—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00013	0.00582	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—focal segmental glomerulosclerosis	0.000119	0.0629	CbGpPWpGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.000109	0.0575	CbGpPWpGaD
Candesartan—Losartan—ACE—focal segmental glomerulosclerosis	0.000101	0.0213	CrCbGaD
Candesartan—AGTR1—Arf6 signaling events—GNAQ—focal segmental glomerulosclerosis	9.49e-05	0.0501	CbGpPWpGaD
Candesartan—Valsartan—ALB—focal segmental glomerulosclerosis	8.5e-05	0.0179	CrCbGaD
Candesartan—AGTR1—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	6.2e-05	0.0327	CbGpPWpGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	5.28e-05	0.0279	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	4.8e-05	0.0253	CbGpPWpGaD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	4.34e-05	0.0229	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—focal segmental glomerulosclerosis	4.24e-05	0.0224	CbGpPWpGaD
Candesartan—Losartan—ALB—focal segmental glomerulosclerosis	4.15e-05	0.00874	CrCbGaD
Candesartan—AGTR1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	3.79e-05	0.02	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—focal segmental glomerulosclerosis	3.6e-05	0.019	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	2.97e-05	0.0157	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	2.92e-05	0.0154	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	2.66e-05	0.014	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	2.48e-05	0.0131	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	2.28e-05	0.0121	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	2.22e-05	0.0117	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	2.21e-05	0.0116	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	1.96e-05	0.0103	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	1.93e-05	0.0102	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	1.9e-05	0.01	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	1.72e-05	0.00909	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	1.6e-05	0.00844	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	1.58e-05	0.00833	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.55e-05	0.00816	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	1.5e-05	0.00793	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	1.49e-05	0.00787	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	1.43e-05	0.00755	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	1.33e-05	0.00701	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	1.3e-05	0.00686	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	1.28e-05	0.00673	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	1.17e-05	0.00618	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	1.17e-05	0.00617	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	1.11e-05	0.00588	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	1.06e-05	0.00559	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	9.91e-06	0.00523	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	9.85e-06	0.0052	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	9.71e-06	0.00513	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	8.76e-06	0.00462	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	8.47e-06	0.00447	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	8.42e-06	0.00444	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	8.3e-06	0.00438	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	8.06e-06	0.00426	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	7.95e-06	0.0042	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	7.69e-06	0.00406	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	7.64e-06	0.00404	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	7.31e-06	0.00386	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	7.08e-06	0.00374	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.56e-06	0.00346	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	6.43e-06	0.00339	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.18e-06	0.00326	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.77e-06	0.00305	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	5.49e-06	0.0029	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—LIPC—focal segmental glomerulosclerosis	5.18e-06	0.00274	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	5.01e-06	0.00265	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.98e-06	0.00263	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CTGF—focal segmental glomerulosclerosis	4.56e-06	0.00241	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	4.56e-06	0.00241	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.54e-06	0.0024	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	4.54e-06	0.0024	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.52e-06	0.00238	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.23e-06	0.00224	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.2e-06	0.00222	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.14e-06	0.00218	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4e-06	0.00211	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.8e-06	0.002	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.73e-06	0.00197	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.45e-06	0.00182	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.42e-06	0.00181	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.4e-06	0.0018	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—LPL—focal segmental glomerulosclerosis	3.16e-06	0.00167	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.03e-06	0.0016	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.94e-06	0.00155	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.92e-06	0.00154	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.86e-06	0.00151	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AGT—focal segmental glomerulosclerosis	2.71e-06	0.00143	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.71e-06	0.00143	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.63e-06	0.00139	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.58e-06	0.00136	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.57e-06	0.00136	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.44e-06	0.00129	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.37e-06	0.00125	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.26e-06	0.00119	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2.24e-06	0.00118	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.21e-06	0.00117	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.1e-06	0.00111	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—focal segmental glomerulosclerosis	2.08e-06	0.0011	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	1.89e-06	0.000996	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.88e-06	0.000992	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.8e-06	0.00095	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	1.78e-06	0.000941	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.7e-06	0.000896	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	1.66e-06	0.000877	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.64e-06	0.000867	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.53e-06	0.00081	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.53e-06	0.000808	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	1.52e-06	0.000805	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.45e-06	0.000764	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.44e-06	0.00076	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.41e-06	0.000742	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.38e-06	0.000729	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.35e-06	0.000713	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.33e-06	0.000704	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.24e-06	0.000657	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.19e-06	0.000626	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	1.17e-06	0.000618	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	1.15e-06	0.000608	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1e-06	0.000529	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	9.84e-07	0.00052	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	9.37e-07	0.000495	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	8.58e-07	0.000453	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	8.01e-07	0.000423	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	7.55e-07	0.000399	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	6.58e-07	0.000348	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	6.15e-07	0.000325	CbGpPWpGaD
